Skip to main content
Cachet Pharmaceutical Co., Ltd. logo

Cachet Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 002462 ISIN · CNE100000SN0 LEI · 300300CBONJS7HUOCX64 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,441 across all filing types
Latest filing 2014-09-10 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 002462

About Cachet Pharmaceutical Co., Ltd.

https://www.cachet.com.cn

Cachet Pharmaceutical Co., Ltd. specializes in the distribution and retail of pharmaceutical products and medical devices. The company operates an extensive wholesale network and a chain of retail pharmacies, providing comprehensive supply chain solutions to healthcare institutions and end-consumers. Its core operations include the procurement, storage, and logistics of western medicines, traditional Chinese medicines, and high-value medical consumables. Cachet Pharmaceutical emphasizes modern logistics management and professional pharmaceutical services, leveraging a robust distribution infrastructure to ensure the efficient delivery of healthcare products. The company also focuses on hospital supply chain integration and community-based retail services to enhance healthcare accessibility.

Recent filings

Filing Released Lang Actions
独立董事候选人声明（吴剑）
Board/Management Information Classification · 95% confidence The document is a detailed declaration statement by an independent director candidate of a company, 嘉事堂药业股份有限公司. It contains personal qualifications, compliance with regulatory requirements, and assurances related to the candidate's independence and eligibility to serve as an independent director. There are no financial statements, earnings data, or report summaries. The content is focused on governance and compliance related to board membership qualifications rather than financial or operational reporting. This type of document fits best under Board/Management Information (MANG), as it relates to announcements or declarations about board members or senior management candidates.
2014-09-10 Chinese
浙江嘉事杰博医疗器械有限公司等四家单位审计报告
Audit Report / Information Classification · 100% confidence The document is titled as an "审计报告" (Audit Report) for 浙江嘉事杰博医疗器械有限公司 and related entities, covering the period from January 1, 2013 to August 26, 2014. It includes detailed audit opinions, financial statements (balance sheet, income statement), and extensive notes on accounting policies and estimates. The content is a full audit report with financial data and auditor's opinion, not merely an announcement or certification. The length is substantial (15,000 characters), and it contains comprehensive financial information and audit details. Therefore, it fits the category of an Audit Report / Information (AR). Q3 2014
2014-09-10 Chinese
对外投资的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding the company's planned acquisitions of significant equity stakes in multiple companies. It includes extensive information about the transaction overview, parties involved, shareholding structures before and after the acquisition, business descriptions, financial data of the target companies, asset valuations, and payment arrangements. The document mentions the use of funds from a convertible bond issuance for these acquisitions. The content is focused on capital transactions and financing activities related to the company's expansion through acquisitions. There is no indication that this is a full annual or interim report, audit report, earnings release, or other types of filings. The document is not a simple announcement of a report publication but a substantive disclosure of financing and capital structure changes due to acquisitions. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2014-09-10 Chinese
前次募集资金使用情况鉴证报告
Audit Report / Information Classification · 95% confidence The document is titled as a "前次募集资金使用情况鉴证报告" which translates to "Verification Report on the Use of Previous Fundraising Proceeds." It is prepared by the company's board and audited by a registered accounting firm. The report details the use of funds raised in a previous capital raising event, including amounts raised, usage, changes in investment projects, and economic benefits realized. It references compliance with regulations from the China Securities Regulatory Commission (CSRC) regarding fundraising usage reports. The document is a standalone audit/verification report on the use of previously raised capital, not a full annual or interim financial report, nor an announcement or presentation. It contains detailed financial data about fundraising usage and audit conclusions. Therefore, it fits the category of an Audit Report / Information (AR). H1 2014
2014-09-10 Chinese
未来三年（2014-2016年）股东回报规划
Notice of Dividend Amount Classification · 85% confidence The document is a detailed statement of the company's shareholder return plan for the years 2014-2016, including principles, specific dividend distribution policies, decision-making procedures, and mechanisms. It is a policy or planning document related to dividends and shareholder returns rather than an announcement of dividend amounts or payment dates. It does not contain financial statements or earnings data, nor is it a report publication announcement or regulatory filing. The content focuses on the company's dividend policy and shareholder return planning, which aligns best with a Notice of Dividend Amount (DIV) category, as it relates to dividend distribution plans and policies. However, since it is a forward-looking shareholder return plan rather than a specific dividend amount announcement, it is closest to DIV as it deals with dividend policy and distribution plans.
2014-09-10 Chinese
公司章程（2014年9月）
Governance Information Classification · 100% confidence The document is titled '嘉事堂药业股份有限公司公司章程' which translates to 'Cachet Pharmaceutical Co., Ltd. Articles of Association'. It contains detailed chapters on company organization, shareholder rights, board of directors, management, financial accounting, profit distribution, auditing, and procedures for meetings and resolutions. The content is a comprehensive set of internal governance rules and regulations for the company, including shareholder meetings, board structure, and management responsibilities. It is not a financial report, earnings release, or announcement but a governance document outlining the company's internal rules and governance practices. Therefore, the document fits the category of Governance Information (CGR). The document length is substantial (15,000 characters), indicating it is the full text of the governance document, not a brief announcement or summary.
2014-09-10 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.